China Myasthenia Gravis Drugs Industry 2017 Market Research Report

 Table of Contents

China Myasthenia Gravis Drugs Market Research Report 2017
1 Myasthenia Gravis Drugs Market Overview
    1.1 Product Overview and Scope of Myasthenia Gravis Drugs
    1.2 Myasthenia Gravis Drugs Segment by Type
        1.2.1 China Production Market Share of Myasthenia Gravis Drugs Type in 2015
        1.2.2 Anticholinesterases
        1.2.3 Immunosuppressants
        1.2.4 Intravenous Immune Globulins
    1.3 Applications of Myasthenia Gravis Drugs
        1.3.1 Myasthenia Gravis Drugs Consumption Market Share by Application in 2015
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 China Market Size (Value) of Myasthenia Gravis Drugs (2012-2022)
    1.5 China Myasthenia Gravis Drugs Status and Outlook
    1.6 Government Policies

2 China Myasthenia Gravis Drugs Market Competition by Manufacturers
    2.1 China Myasthenia Gravis Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
    2.2 China Myasthenia Gravis Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.3 China Myasthenia Gravis Drugs Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Myasthenia Gravis Drugs Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Myasthenia Gravis Drugs Market Competitive Situation and Trends
        2.5.1 Myasthenia Gravis Drugs Market Concentration Rate
        2.5.2 Myasthenia Gravis Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Myasthenia Gravis Drugs Manufacturers Profiles/Analysis
    3.1 Flamel Technologies
        3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.1.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.1.2.1 Product A
            3.1.2.2 Product B
        3.1.3 Flamel Technologies Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.1.4 Main Business/Business Overview
    3.2 F. Hoffmann-La Roche
        3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.2.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.2.2.1 Product A
            3.2.2.2 Product B
        3.2.3 F. Hoffmann-La Roche Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.2.4 Main Business/Business Overview
    3.3 Grifols
        3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.3.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.3.2.1 Product A
            3.3.2.2 Product B
        3.3.3 Grifols Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.3.4 Main Business/Business Overview
    3.4 Pfizer
        3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.4.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.4.2.1 Product A
            3.4.2.2 Product B
        3.4.3 Pfizer Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.4.4 Main Business/Business Overview
    3.5 Shire
        3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.5.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.5.2.1 Product A
            3.5.2.2 Product B
        3.5.3 Shire Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.5.4 Main Business/Business Overview
    3.6 Novartis
        3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.6.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.6.2.1 Product A
            3.6.2.2 Product B
        3.6.3 Novartis Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.6.4 Main Business/Business Overview
    3.7 Valeant Pharmaceuticals
        3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.7.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.7.2.1 Product A
            3.7.2.2 Product B
        3.7.3 Valeant Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.7.4 Main Business/Business Overview
    3.8 Alexion Pharmaceuticals
        3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.8.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.8.2.1 Product A
            3.8.2.2 Product B
        3.8.3 Alexion Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.8.4 Main Business/Business Overview
    3.9 Catalyst Pharmaceuticals
        3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.9.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.9.2.1 Product A
            3.9.2.2 Product B
        3.9.3 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.9.4 Main Business/Business Overview
    3.10 CSL
        3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        3.10.2 Myasthenia Gravis Drugs Product Type, Application and Specification
            3.10.2.1 Product A
            3.10.2.2 Product B
        3.10.3 CSL Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
        3.10.4 Main Business/Business Overview
    3.11 Curavac
    3.12 Cytokinetics
    3.13 Galencia
    3.14 GlaxoSmithKline
    3.15 Lupin Pharmaceuticals
    3.16 Mitsubishi Tanabe Pharma

4 China Myasthenia Gravis Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
    4.1 China Myasthenia Gravis Drugs Capacity, Production and Growth (2012-2017)
    4.2 China Myasthenia Gravis Drugs Revenue and Growth (2012-2017)
    4.3 China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

5 China Myasthenia Gravis Drugs Production, Revenue (Value), Price Trend by Type
    5.1 China Myasthenia Gravis Drugs Production and Market Share by Type (2012-2017)
    5.2 China Myasthenia Gravis Drugs Revenue and Market Share by Type (2012-2017)
    5.3 China Myasthenia Gravis Drugs Price by Type (2012-2017)
    5.4 China Myasthenia Gravis Drugs Production Growth by Type (2012-2017)

6 China Myasthenia Gravis Drugs Market Analysis by Application
    6.1 China Myasthenia Gravis Drugs Consumption and Market Share by Application (2012-2017)
    6.2 China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Application
        6.3.2 Emerging Markets/Countries

7 ChinaMyasthenia Gravis Drugs Market Analysis by Regions (Provinces)
    7.1 China Myasthenia Gravis Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
        7.1.1 China Myasthenia Gravis Drugs Production and Market Share by Regions (Provinces)(2012-2017)
        7.1.2 China Myasthenia Gravis Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
        7.1.3 China Myasthenia Gravis Drugs Sales Price by Regions (Provinces)(2012-2017)
    7.2 China Myasthenia Gravis Drugs Consumption by Regions (Provinces)(2012-2017)
    7.3 China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)

8 Myasthenia Gravis Drugs Manufacturing Cost Analysis
    8.1 Myasthenia Gravis Drugs Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Price Trend of Key Raw Materials
        8.1.3 Key Suppliers of Raw Materials
        8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Myasthenia Gravis Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Myasthenia Gravis Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Myasthenia Gravis Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 China Myasthenia Gravis Drugs Market Forecast (2017-2022)
    12.1 China Myasthenia Gravis Drugs Capacity, Production, Revenue Forecast (2017-2022)
    12.2 China Myasthenia Gravis Drugs Production, Import, Export and Consumption Forecast (2017-2022)
    12.3 China Myasthenia Gravis Drugs Production Forecast by Type (2017-2022)
    12.4 China Myasthenia Gravis Drugs Consumption Forecast by Application (2017-2022)
    12.5 China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
        12.5.1 China Myasthenia Gravis Drugs Production Forecast by Regions (Provinces)(2017-2022)
        12.5.2 China Myasthenia Gravis Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
        12.5.3 China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
    12.6 Myasthenia Gravis Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Picture of Myasthenia Gravis Drugs
    Figure China Production Market Share of Myasthenia Gravis Drugs by Type in 2015
    Figure Product Picture of Anticholinesterases
    Table Major Manufacturers of Anticholinesterases
    Figure Product Picture of Immunosuppressants
    Table Major Manufacturers of Immunosuppressants
    Figure Product Picture of Intravenous Immune Globulins
    Table Major Manufacturers of Intravenous Immune Globulins
    Table Myasthenia Gravis Drugs Consumption Market Share by Application in 2015
    Figure Hospitals Examples
    Figure Clinics Examples
    Figure China Myasthenia Gravis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Table China Myasthenia Gravis Drugs Capacity of Key Manufacturers (2015 and 2016)
    Table China Myasthenia Gravis Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
    Figure China Myasthenia Gravis Drugs Capacity of Key Manufacturers in 2015
    Figure China Myasthenia Gravis Drugs Capacity of Key Manufacturers in 2016
    Table China Myasthenia Gravis Drugs Production of Key Manufacturers (2015 and 2016)
    Table China Myasthenia Gravis Drugs Production Share by Manufacturers (2015 and 2016)
    Figure 2015 Myasthenia Gravis Drugs Production Share by Manufacturers
    Figure 2016 Myasthenia Gravis Drugs Production Share by Manufacturers
    Table China Myasthenia Gravis Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
    Table China Myasthenia Gravis Drugs Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 China Myasthenia Gravis Drugs Revenue Share by Manufacturers
    Table 2016 China Myasthenia Gravis Drugs Revenue Share by Manufacturers
    Table China Market Myasthenia Gravis Drugs Average Price of Key Manufacturers (2015 and 2016)
    Figure China Market Myasthenia Gravis Drugs Average Price of Key Manufacturers in 2015
    Table Manufacturers Myasthenia Gravis Drugs Manufacturing Base Distribution and Sales Area
    Table Manufacturers Myasthenia Gravis Drugs Product Type
    Figure Myasthenia Gravis Drugs Market Share of Top 3 Manufacturers
    Figure Myasthenia Gravis Drugs Market Share of Top 5 Manufacturers
    Table Flamel Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Flamel Technologies Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Flamel Technologies Myasthenia Gravis Drugs Market Share (2012-2017)
    Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table F. Hoffmann-La Roche Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure F. Hoffmann-La Roche Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Grifols Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Grifols Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Pfizer Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Pfizer Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Shire Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Shire Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Novartis Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Valeant Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Valeant Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Alexion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Alexion Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Alexion Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Catalyst Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Catalyst Pharmaceuticals Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure Catalyst Pharmaceuticals Myasthenia Gravis Drugs Market Share (2012-2017)
    Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table CSL Myasthenia Gravis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    Figure CSL Myasthenia Gravis Drugs Market Share (2012-2017)
    Table Curavac Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Cytokinetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Galencia Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Lupin Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Figure China Myasthenia Gravis Drugs Capacity, Production and Growth (2012-2017)
    Figure China Myasthenia Gravis Drugs Revenue (Million USD) and Growth (2012-2017)
    Table China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)
    Table China Myasthenia Gravis Drugs Production by Type (2012-2017)
    Table China Myasthenia Gravis Drugs Production Share by Type (2012-2017)
    Figure Production Market Share of Myasthenia Gravis Drugs by Type (2012-2017)
    Figure 2015 Production Market Share of Myasthenia Gravis Drugs by Type
    Table China Myasthenia Gravis Drugs Revenue by Type (2012-2017)
    Table China Myasthenia Gravis Drugs Revenue Share by Type (2012-2017)
    Figure Production Revenue Share of Myasthenia Gravis Drugs by Type (2012-2017)
    Figure 2015 Revenue Market Share of Myasthenia Gravis Drugs by Type
    Table China Myasthenia Gravis Drugs Price by Type (2012-2017)
    Figure China Myasthenia Gravis Drugs Production Growth by Type (2012-2017)
    Table China Myasthenia Gravis Drugs Consumption by Application (2012-2017)
    Table China Myasthenia Gravis Drugs Consumption Market Share by Application (2012-2017)
    Figure China Myasthenia Gravis Drugs Consumption Market Share by Application in 2015
    Table China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)
    Figure China Myasthenia Gravis Drugs Consumption Growth Rate by Application (2012-2017)
    Table China Myasthenia Gravis Drugs Production by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Production Market Share by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Production Value by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Sales Price by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Consumption by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
    Table China Myasthenia Gravis Drugs Production, Consumption, Export and Import (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Myasthenia Gravis Drugs
    Figure Manufacturing Process Analysis of Myasthenia Gravis Drugs
    Figure Myasthenia Gravis Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Myasthenia Gravis Drugs Major Manufacturers in 2015
    Table Major Buyers of Myasthenia Gravis Drugs
    Table Distributors/Traders List
    Figure China Myasthenia Gravis Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
    Figure China Myasthenia Gravis Drugs Revenue and Growth Rate Forecast (2017-2022)
    Table China Myasthenia Gravis Drugs Production, Import, Export and Consumption Forecast (2017-2022)
    Table China Myasthenia Gravis Drugs Production Forecast by Type (2017-2022)
    Table China Myasthenia Gravis Drugs Consumption Forecast by Application (2017-2022)
    Table China Myasthenia Gravis Drugs Production Forecast by Regions (Provinces)(2017-2022)
    Table China Myasthenia Gravis Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
    Table China Myasthenia Gravis Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy